Alembic Pharmaceuticals Limited - Special Call Transcript
Ladies and gentlemen, good day and welcome to the discussion on impact of COVID-19. We have with us today on the call Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Pranav Amin. Thank you, and over to you, sir.
Thank you. Good afternoon, everyone, and thank you all for joining our conference call. The reason for this is that we had multiple requests for a call about this topic and Alembic and the pharmaceutical outlook. And instead of individual calls, we thought we will just do one, where we address all of you together.
Before I get to the COVID pandemic, let me address the FDA issue that we recently had at F1, our main formulation plant for the U.S. and the European markets. We had 2 auditors who spent a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
